期刊
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
卷 104, 期 8, 页码 3433-3444出版社
SPRINGER
DOI: 10.1007/s00253-020-10447-9
关键词
Synthetic biology; Genetic engineering; Non-proteinogenic amino acids; D-amino acids; Phenylglycine; Actinomycetes
资金
- Projekt DEAL
- Institutional Strategy of the University of Tubingen (Deutsche Forschungsgemeinschaft) [ZUK 63]
- Baden-Wurttemberg Stiftung [BWST_WSF035]
- German Center for Infection research (DZIF) [TTU 09.819]
L-phenylglycine (L-Phg) is a rare non-proteinogenic amino acid, which only occurs in some natural compounds, such as the streptogramin antibiotics pristinamycin I and virginiamycin S or the bicyclic peptide antibiotic dityromycin. Industrially, more interesting than L-Phg is the enantiomeric D-Phg as it plays an important role in the fine chemical industry, where it is used as a precursor for the production of semisynthetic beta-lactam antibiotics. Based on the natural L-Phg operon from Streptomyces pristinaespiralis and the stereo-inverting aminotransferase gene hpgAT from Pseudomonas putida, an artificial D-Phg operon was constructed. The natural L-Phg operon, as well as the artificial D-Phg operon, was heterologously expressed in different actinomycetal host strains, which led to the successful production of Phg. By rational genetic engineering of the optimal producer strains S. pristinaespiralis and Streptomyces lividans, Phg production could be improved significantly. Here, we report on the development of a synthetic biology-derived D-Phg pathway and the optimization of fermentative Phg production in actinomycetes by genetic engineering approaches. Our data illustrate a promising alternative for the production of Phgs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据